Cover Image
市場調查報告書

色素沉著過度症治療市場:各治療方法(局部治療藥,雷射,果酸換膚,微晶換膚術,光線療法),適應症,終端用戶,地區 - 產業分析,市場規模,佔有率,成長,趨勢,預測 2018年∼2026年

Hyperpigmentation Disorders Treatment Market (Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion; Disease Indication; End use) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

出版商 Transparency Market Research 商品編碼 671144
出版日期 內容資訊 英文 201 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
色素沉著過度症治療市場:各治療方法(局部治療藥,雷射,果酸換膚,微晶換膚術,光線療法),適應症,終端用戶,地區 - 產業分析,市場規模,佔有率,成長,趨勢,預測 2018年∼2026年 Hyperpigmentation Disorders Treatment Market (Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion; Disease Indication; End use) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
出版日期: 2018年07月10日 內容資訊: 英文 201 Pages
簡介

本報告提供全球色素沉著過度症治療市場調查,市場概要,各治療方法、適應症、終端用戶、地區的市場規模的變化與預測,市場佔有率,市場趨勢,市場成長、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 調查範圍和市場區隔
  • 調查的重點

第2章 前提條件與調查方法

  • 前提條件
  • 調查方法

第3章 摘要整理

第4章 市場概要

  • 市場概要
  • 市場規模的變化與預測
  • 市場預測
  • 波特的五力分析
  • 開發平台分析
  • 主要的收購、聯盟案例
  • 法律制度:各地區
  • 疾病罹患率和盛行率
  • 價格分析

第5章 市場動態

  • 成長要素
  • 阻礙因素
  • 市場機會分析
  • 市場機會
  • 市場趨勢

第6章 色素沉著過度症治療市場分析:各治療法

  • 簡介
  • 市場佔有率分析:各治療法
  • 市場分析:各治療法
    • 局部治療藥
    • 雷射
    • 果酸換膚
    • 微晶換膚術
    • 光線療法
    • 其他
  • 市場魅力分析:各治療法

第7章 色素沉著過度症治療市場分析:各適應症

  • 簡介
  • 市場佔有率分析:各適應症
  • 市場分析:各適應症
    • 黑皮症
    • 發炎後色素沉著過度症
    • 老人性色素班
    • 其他
  • 市場魅力分析:各適應症

第8章 色素沉著過度症治療市場分析:各終端用戶

  • 簡介
  • 市場佔有率分析:各終端用戶
  • 市場分析:各終端用戶
    • 醫院
    • 美容診所、皮膚中心
    • 其他
  • 市場魅力分析:各終端用戶

第9章 色素沉著過度症治療市場分析:各地區

  • 簡介
  • 市場佔有率分析:各地區
  • 市場分析:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場魅力分析:各地區

第10章 北美

第11章 歐洲

第12章 亞太地區

第13章 南美

第14章 中東、非洲

第15章 競爭情形

  • 競爭矩陣
  • 市場佔有率分析:各地區
  • 企業簡介
    • Bayer AG
    • ALLERGAN
    • Galderma SA (Nestle Skin Health SA)
    • SkinCeuticals
    • Pierre Fabre
    • EpiPharm AG
    • RXi Pharmaceuticals Corporation
    • Obagi Cosmeceuticals LLC (Obagi medical)
    • Vivier Pharma
目錄

Title:
Hyperpigmentation Disorders Treatment Market (Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion; Disease Indication - Melasma, Post-inflammatory Hyperpigmentation, Solar Lentigines; End use - Hospitals, Aesthetic Clinics & Dermatology Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global Hyperpigmentation Disorders Treatment Market: Overview

This report analyzes the global hyperpigmentation disorders treatment market in terms of its current and future scenario. Rise in investment in R&D of novel advanced technologies, decrease in social taboos regarding pigmentation, increase in prevalence of hyperpigmentation-related disorders, and rise in awareness about skin rejuvenation and treatment options are likely to drive the growth of the global market during the forecast period. Anti-pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, and laser therapy. These therapies are available in hospitals and aesthetic clinics & dermatology centers.

This report on the global hyperpigmentation disorders treatment market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on product type, application, and geography. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of geography, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global hyperpigmentation disorders treatment market.

Global Hyperpigmentation Disorders Treatment Market: Key Segments

The global hyperpigmentation disorders treatment market has been segmented into topical drugs, laser therapy, chemical peels, microdermabrasion, phototherapy, and others, based on treatment type. By disease indication, the market has been classified into melasma, post-inflammatory hyperpigmentation, solar lentigines, and others. In terms of end-user, the market has been segmented into hospitals, aesthetic clinics & dermatology centers, and others. The global hyperpigmentation disorders treatment market has been analyzed based on increasing prevalence of hyperpigmentation disorders, technology trend, expenditure on emerging technologies, and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period, i.e. from 2018 to 2026, considering 2017 as the base year.

Global Hyperpigmentation Disorders Treatment Market: Regional Outlook

Geographically, the global hyperpigmentation disorders treatment market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period, viz. 2018-2026, considering 2017 as the base year. This report also covers the competitive scenario of the market in these regions.

Companies Mentioned in Report

The report profiles the major players operating in the global hyperpigmentation disorders treatment market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report are Bayer AG, ALLERGAN, Galderma S.A., SkinCeuticals, Pierre Fabre, EpiPharm AG, RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC, and Vivier Pharma.

The global hyperpigmentation disorders treatment market has been segmented as follows:

Hyperpigmentation Disorders Treatment Market, by Treatment Type

  • Topical Drugs
  • Laser Therapy
  • Chemical Peels
  • Microdermabrasion
  • Phototherapy
  • Others

Hyperpigmentation Disorders Treatment Market, by Disease Indication

  • Melasma
  • Post-inflammatory Hyperpigmentation
  • Solar Lentigines
  • Others

Hyperpigmentation Disorders Treatment Market, by End-user

  • Hospitals
  • Aesthetic Clinics & Dermatology Centers
  • Others

Hyperpigmentation Disorders Treatment Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia-pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Table of Contents

Section 01: Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

Section 02: Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Research Methodology

Section 03: Executive Summary

  • 3.1. Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) and Distribution by Geography, 2017 and 2026
  • 3.2. Global Hyperpigmentation Disorders Treatment Market Snapshot, 2017
  • 3.3. Global Hyperpigmentation Disorders Treatment Market: Opportunity Map

Section 04: Market Overview

  • 4.1. Overview
  • 4.2. Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, 2016-2026
  • 4.3. Global Hyperpigmentation Disorders Treatment Market Outlook
  • 4.4. Global Hyperpigmentation Disorders Treatment Market: Porter's Five Forces Analysis
  • 4.5. Hyperpigmentation Disorders Treatment Market: Pipeline Analysis
  • 4.6. Key Partnership & Acquisitions
  • 4.7. Policies and Regulations: By Region
  • 4.8. Disease Prevalence and Incidence Rate Globally
  • 4.9. Global Hyperpigmentation Disorders Treatment Market: Pricing Assessment

Section 05: Market Dynamics

  • 5.1. Drivers
  • 5.2. Restraints
  • 5.3. Opportunity Analysis
  • 5.4. Opportunities
  • 5.5. Trends

Section 06: Global Hyperpigmentation Disorders Treatment Market Analysis, by Treatment Type

  • 6.1. Introduction
  • 6.2. Global Hyperpigmentation Disorders Treatment Market Value Share Analysis, by Treatment Type
  • 6.3. Hyperpigmentation Disorders Treatment Market Analysis, by Treatment Type
    • 6.3.1. Topical Drugs
    • 6.3.2. Laser Therapy
    • 6.3.3. Chemical Peels
    • 6.3.4. Microdermabrasion
    • 6.3.5. Phototherapy
    • 6.3.6. Others
  • 6.4. Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment Type

Section 07: Global Hyperpigmentation Disorders Treatment Market Analysis, by Disease Indication

  • 7.1. Introduction
  • 7.2. Global Hyperpigmentation Disorders Treatment Market Value Share Analysis, by Disease Indication
  • 7.3. Hyperpigmentation Disorders Treatment Market Analysis, by Disease Indication
    • 7.3.1. Melasma
    • 7.3.2. Post-inflammatory Hyperpigmentation
    • 7.3.3. Solar Lentigines
    • 7.3.4. Others
  • 7.4. Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication

Section 08: Global Hyperpigmentation Disorders Treatment Market Analysis, by End-user

  • 8.1. Introduction
  • 8.2. Global Hyperpigmentation Disorders Treatment Market Value Share Analysis, by End-user
  • 8.3. Hyperpigmentation Disorders Treatment Market Analysis, by End-user
    • 8.3.1. Hospitals
    • 8.3.2. Aesthetic Clinics & Dermatology Centers
    • 8.3.3. Others
  • 8.4. Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by End-user

Section 09: Global Hyperpigmentation Disorders Treatment Market Analysis, by Region

  • 9.1. Global Hyperpigmentation Disorders Treatment Market Snapshot, by Country
  • 9.2. Global Hyperpigmentation Disorders Treatment Market Value Share Analysis, by Region
  • 9.3. Hyperpigmentation Disorders Treatment Market Forecast, by Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa
  • 9.4. Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Region

Section 10: North America Hyperpigmentation Disorders Treatment Market Analysis

  • 10.1. Key Findings
  • 10.2. North America Hyperpigmentation Disorders Treatment Market Overview
  • 10.3. North America Market Value Share Analysis, by Treatment Type
  • 10.4. North America Market Forecast, by Treatment Type
    • 10.4.1. Topical Drugs
    • 10.4.2. Laser Therapy
    • 10.4.3. Chemical Peels
    • 10.4.4. Microdermabrasion
    • 10.4.5. Phototherapy
    • 10.4.6. Others
  • 10.5. North America Market Value Share Analysis, by Disease Indication
  • 10.6. North America Market Forecast, by Disease Indication
    • 10.6.1. Melasma
    • 10.6.2. Post-inflammatory Hyperpigmentation
    • 10.6.3. Solar Lentigines
    • 10.6.4. Others
  • 10.7. North America Market Value Share Analysis, by End-user
  • 10.8. North America Market Forecast, by End-user
    • 10.8.1. Hospitals
    • 10.8.2. Aesthetic Clinics & Dermatology Centers
    • 10.8.3. Others
  • 10.9. Market Analysis, by Country
  • 10.10. Market Value Share Analysis, by Country
  • 10.11. Market Size (US$ Mn) Forecast, by Country, 2018-2026
    • 10.11.1. U.S.
    • 10.11.2. Canada
  • 10.12. Market Attractiveness Analysis
    • 10.12.1. By Treatment Type
    • 10.12.2. By Disease Indication
    • 10.12.3. By End-user
    • 10.12.4. By Country

Section 11: Europe Hyperpigmentation Disorders Treatment Market Analysis

  • 11.1. Key Findings
  • 11.2. Europe Hyperpigmentation Disorders Treatment Market Overview
  • 11.3. Europe Market Value Share Analysis, by Treatment Type
  • 11.4. Europe Market Forecast, by Treatment Type
    • 11.4.1. Topical Drugs
    • 11.4.2. Laser Therapy
    • 11.4.3. Chemical Peels
    • 11.4.4. Microdermabrasion
    • 11.4.5. Phototherapy
    • 11.4.6. Others
  • 11.5. Europe Market Value Share Analysis, by Disease Indication
  • 11.6. Europe Market Forecast, by Disease Indication
    • 11.6.1. Melasma
    • 11.6.2. Post-inflammatory Hyperpigmentation
    • 11.6.3. Solar Lentigines
    • 11.6.4. Others
  • 11.7. Europe Market Value Share Analysis, by End-user
  • 11.8. Europe Market Forecast, by End-user
    • 11.8.1. Hospitals
    • 11.8.2. Aesthetic Clinics & Dermatology Centers
    • 11.8.3. Others
  • 11.9. Market Analysis, by Country
  • 11.10. Market Value Share Analysis, by Country
  • 11.11. Market Size (US$ Mn) Forecast, by Country, 2018-2026
    • 11.11.1. Germany
    • 11.11.2. France
    • 11.11.3. U.K.
    • 11.11.4. Italy
    • 11.11.5. Spain
    • 11.11.6. Rest of Europe
  • 11.12. Market Attractiveness Analysis
    • 11.12.1. By Treatment Type
    • 11.12.2. By Disease Indication
    • 11.12.3. By End-user
    • 11.12.4. By Country

Section 12: Asia Pacific Hyperpigmentation Disorders Treatment Market Analysis

  • 12.1. Key Findings
  • 12.2. Asia Pacific Hyperpigmentation Disorders Treatment Market Overview
  • 12.3. Asia Pacific Market Value Share Analysis, by Treatment Type
  • 12.4. Asia Pacific Market Forecast, by Treatment Type
    • 12.4.1. Topical Drugs
    • 12.4.2. Laser Therapy
    • 12.4.3. Chemical Peels
    • 12.4.4. Microdermabrasion
    • 12.4.5. Phototherapy
    • 12.4.6. Others
  • 12.5. Asia Pacific Market Value Share Analysis, by Disease Indication
  • 12.6. Asia Pacific Market Forecast, by Disease Indication
    • 12.6.1. Melasma
    • 12.6.2. Post-inflammatory Hyperpigmentation
    • 12.6.3. Solar Lentigines
    • 12.6.4. Others
  • 12.7. Asia Pacific Market Value Share Analysis, by End-user
  • 12.8. Asia Pacific Market Forecast, by End-user
    • 12.8.1. Hospitals
    • 12.8.2. Aesthetic Clinics & Dermatology Centers
    • 12.8.3. Others
  • 12.9. Market Analysis, by Country
  • 12.10. Market Value Share Analysis, by Country
  • 12.11. Market Size (US$ Mn) Forecast, by Country, 2018-2026
    • 12.11.1. China
    • 12.11.2. Japan
    • 12.11.3. India
    • 12.11.4. Australia & New Zealand
    • 12.11.5. Rest of Asia Pacific
  • 12.12. Market Attractiveness Analysis
    • 12.12.1. By Treatment Type
    • 12.12.2. By Disease Indication
    • 12.12.3. By End-user
    • 12.12.4. By Country

Section 13: Latin America Hyperpigmentation Disorders Treatment Market Analysis

  • 13.1. Key Findings
  • 13.2. Latin America Hyperpigmentation Disorders Treatment Market Overview
  • 13.3. Latin America Market Value Share Analysis, by Treatment Type
  • 13.4. Latin America Market Forecast, by Treatment Type
    • 13.4.1. Topical Drugs
    • 13.4.2. Laser Therapy
    • 13.4.3. Chemical Peels
    • 13.4.4. Microdermabrasion
    • 13.4.5. Phototherapy
    • 13.4.6. Others
  • 13.5. Latin America Market Value Share Analysis, by Disease Indication
  • 13.6. Latin America Market Forecast, by Disease Indication
    • 13.6.1. Melasma
    • 13.6.2. Post-inflammatory Hyperpigmentation
    • 13.6.3. Solar Lentigines
    • 13.6.4. Others
  • 13.7. Latin America Market Value Share Analysis, by End-user
  • 13.8. Latin America Market Forecast, by End-user
    • 13.8.1. Hospitals
    • 13.8.2. Aesthetic Clinics & Dermatology Centers
    • 13.8.3. Others
  • 13.9. Market Analysis, by Country
  • 13.10. Market Value Share Analysis, by Country
  • 13.11. Market Size (US$ Mn) Forecast, by Country, 2018-2026
    • 13.11.1. Brazil
    • 13.11.2. Mexico
    • 13.11.3. Rest of Latin America
  • 13.12. Market Attractiveness Analysis
    • 13.12.1. By Treatment Type
    • 13.12.2. By Disease Indication
    • 13.12.3. By End-user
    • 13.12.4. By Country

Section 14: Middle East & Africa Hyperpigmentation Disorders Treatment Market Analysis

  • 14.1. Key Findings
  • 14.2. Middle East & Africa Hyperpigmentation Disorders Treatment Market Overview
  • 14.3. Middle East & Africa Market Value Share Analysis, by Treatment Type
  • 14.4. Middle East & Africa Market Forecast, by Treatment Type
    • 14.4.1. Topical Drugs
    • 14.4.2. Laser Therapy
    • 14.4.3. Chemical Peels
    • 14.4.4. Microdermabrasion
    • 14.4.5. Phototherapy
    • 14.4.6. Others
  • 14.5. Middle East & Africa Market Value Share Analysis, by Disease Indication
  • 14.6. Middle East & Africa Market Forecast, by Disease Indication
    • 14.6.1. Melasma
    • 14.6.2. Post-inflammatory Hyperpigmentation
    • 14.6.3. Solar Lentigines
    • 14.6.4. Others
  • 14.7. Middle East & Africa Market Value Share Analysis, by End-user
  • 14.8. Middle East & Africa Market Forecast, by End-user
    • 14.8.1. Hospitals
    • 14.8.2. Aesthetic Clinics & Dermatology Centers
    • 14.8.3. Others
  • 14.9. Market Analysis, by Country
  • 14.10. Market Value Share Analysis, by Country
  • 14.11. Market Size (US$ Mn) Forecast, by Country, 2018-2026
    • 14.11.1. GCC Countries
    • 14.11.2. South Africa
    • 14.11.3. Rest of Middle East & Africa
  • 14.12. Market Attractiveness Analysis
    • 14.12.1. By Treatment Type
    • 14.12.2. By Disease Indication
    • 14.12.3. By End-user
    • 14.12.4. By Country

Section 15: Competition Landscape

  • 15.1. Competition Matrix
  • 15.2. Hyperpigmentation Disorders Treatment Market Share Analysis, by Company (2017)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Strategic Overview
      • 15.3.1.5. Financial Overview
    • 15.3.2. ALLERGAN
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Strategic Overview
      • 15.3.2.5. Financial Overview
    • 15.3.3. Galderma S.A. (Nestle Skin Health S.A)
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Strategic Overview
    • 15.3.4. SkinCeuticals
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Strategic Overview
    • 15.3.5. Pierre Fabre
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Strategic Overview
      • 15.3.5.5. Financial Overview
    • 15.3.6. EpiPharm AG
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Strategic Overview
    • 15.3.7. RXi Pharmaceuticals Corporation
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Strategic Overview
      • 15.3.7.5. Financial Overview
    • 15.3.8. Obagi Cosmeceuticals LLC (Obagi medical)
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Strategic Overview
    • 15.3.9. Vivier Pharma
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Strategic Overview

List of Tables

  • Table 01: Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016-2026
  • Table 02: Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 03: Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 04: Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Region, 2016-2026
  • Table 05: North America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country, 2016-2026
  • Table 06: North America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016-2026
  • Table 07: North America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 08: North America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 09: Europe Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 10: Europe Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016-2026
  • Table 11: Europe Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 12: Europe Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 13: Asia Pacific Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 14: Asia Pacific Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016-2026
  • Table 15: Asia Pacific Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 16: Asia Pacific Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 17: Latin America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 18: Latin America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016-2026
  • Table 19: Latin America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 20: Latin America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 21: Middle East & Africa Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 22: Middle East & Africa Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016-2026
  • Table 23: Middle East & Africa Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 24: Middle East & Africa Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 25: Bayer AG Business Overview
  • Table 26: Allergan Business Overview
  • Table 27: Galderma S.A. Business Overview
  • Table 28: SkinCeuticals Business Overview
  • Table 29: Pierre Fabre Business Overview
  • Table 30: EpiPharm AG Business Overview
  • Table 31: RXi Pharmaceuticals Corporation Business Overview
  • Table 32: Obagi Cosmeceuticals LLC Business Overview
  • Table 33: Vivier Pharma Business Overview

List of Figures

  • Figure 01: Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 02: Global Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 04: Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017
  • Figure 06: Hyperpigmentation Disorders Treatment Market Value Share, by Region, 2017
  • Figure 03: Hyperpigmentation Disorders Treatment Market Value Share, by Treatment Type, 2017
  • Figure 05: Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017
  • Figure 07: Global Hyperpigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 08: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical Drugs, 2016-2026
  • Figure 09: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laser Therapy, 2016-2026
  • Figure 10: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Peels, 2016-2026
  • Figure 11: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microdermabrasion, 2016-2026
  • Figure 12: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phototherapy, 2016-2026
  • Figure 13: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016-2026
  • Figure 14: Global Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment, 2018-2026
  • Figure 15: Global Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 16: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Melasma, 2016-2026
  • Figure 17: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-inflammatory Hyperpigmentation, 2016-2026
  • Figure 18: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Solar Lentigines, 2016-2026
  • Figure 19: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016-2026
  • Figure 20: Global Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication, 2018-2026
  • Figure 21: Global Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 22: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016-2026
  • Figure 23: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aesthetic Clinics & Dermatology Centers, 2016-2026
  • Figure 24: Global Hyperpigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016-2026
  • Figure 25: Global Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 26: Global Hyperpigmentation Disorders Treatment Market Value Share, by Region, 2017 and 2026
  • Figure 27: Global Hyperpigmentation Disorders Treatment Market Attractiveness Analysis, by Region, 2018-2026
  • Figure 28: North America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 29: North America Hyperpigmentation Disorders Treatment Market Value Share, by Country, 2017 and 2026
  • Figure 30: North America Hyperpigmentation Disorders Treatment Market Attractiveness, by Country, 2018-2026
  • Figure 31: North America Hyperpigmentation Disorders Treatment Market Value Share, by Treatment Type, 2017 and 2026
  • Figure 32: North America Hyperpigmentation Disorders Treatment Market Attractiveness, by Treatment Type, 2018-2026
  • Figure 33: North America Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 34: North America Hyperpigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 35: North America Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 36: North America Hyperpigmentation Disorders Treatment Market Attractiveness, by End-user, 2018-2026
  • Figure 37: Europe Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 38: Europe Hyperpigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 39: Europe Hyperpigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 40: Europe Hyperpigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 41: Europe Hyperpigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018-2026
  • Figure 42: Europe Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 43: Europe Hyperpigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 44: Europe Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 45: Europe Hyperpigmentation Disorders Treatment Market Attractiveness, by End-user, 2018-2026
  • Figure 46: Asia Pacific Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 47: Asia Pacific Hyperpigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 48: Asia Pacific Hyperpigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 49: Asia Pacific Hyperpigmentation Disorders Treatment Market Value Share, by Treatment Type, 2017 and 2026
  • Figure 50: Asia Pacific Hyperpigmentation Disorders Treatment Market Attractiveness, by Treatment Type, 2018-2026
  • Figure 51: Asia Pacific Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 52: Asia Pacific Hyperpigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 53: Asia Pacific Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 54: Asia Pacific Hyperpigmentation Disorders Treatment Market Attractiveness, by End-user, 2018-2026
  • Figure 55: Latin America Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 56: Latin America Hyperpigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 57: Latin America Hyperpigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 58: Latin America Hyperpigmentation Disorders Treatment Market Value Share, by Treatment Type, 2017 and 2026
  • Figure 59: Latin America Hyperpigmentation Disorders Treatment Market Attractiveness, by Treatment Type, 2018-2026
  • Figure 60: Latin America Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 61: Latin America Hyperpigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 62: Latin America Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 63: Latin America Hyperpigmentation Disorders Treatment Market Attractiveness, by End-user, 2018-2026
  • Figure 64: Middle East & Africa Hyperpigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 65: Middle East & Africa Hyperpigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 66: Middle East & Africa Hyperpigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 67: Middle East & Africa Hyperpigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
  • Figure 68: Middle East & Africa Hyperpigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018-2026
  • Figure 69: Middle East & Africa Hyperpigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 70: Middle East & Africa Hyperpigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 71: Middle East & Africa Hyperpigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
  • Figure 72: Middle East & Africa Hyperpigmentation Disorders Treatment Market Attractiveness, by End-user, 2018-2026
Back to Top